Back
Seelos Therapeutics Vs. Citius Pharmaceuticals Industry Stock Comparison
Sell
9
SEEL
Seelos Therapeutics
Last Price:
0.69
Seasonality Move:
23.79%
Sell
20
CTXR
Citius Pharmaceuticals
Last Price:
0.35
Seasonality Move:
14.95%
Sell
9
Seelos Therapeutics (SEEL)
is a Sell
Is Seelos Therapeutics a Buy, Sell or Hold?
- The current Seelos Therapeutics [SEEL] share price is $0.92. The Score for SEEL is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
- SEEL is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
20
Citius Pharmaceuticals (CTXR)
is a Sell
Is Citius Pharmaceuticals a Buy, Sell or Hold?
- The current Citius Pharmaceuticals [CTXR] share price is $0.35. The Score for CTXR is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- CTXR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
SEEL Stock Price Chart
What is Seelos Therapeutics's stock price today?
-
The Seelos Therapeutics share price today is $0.92
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SEEL is experiencing selling pressure, which indicates risk of future bearish movement.
CTXR Stock Price Chart
What is Citius Pharmaceuticals's stock price today?
-
The Citius Pharmaceuticals share price today is $0.35
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTXR is experiencing selling pressure, which indicates risk of future bearish movement.
SEEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.2 | Sell |
| Relative Strength Index (14 RSI): | 30.55 | Sell |
| Chaikin Money Flow: | -9443 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.97 - 2.95) | Sell |
| Bollinger Bands (100): | (-0.1 - 1.88) | Buy |
CTXR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 35.4 | Sell |
| Chaikin Money Flow: | -511717 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.35 - 0.43) | Sell |
| Bollinger Bands (100): | (0.42 - 0.78) | Sell |
SEEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.09 | Sell |
| 20-day SMA: | 1.61 | Sell |
| 50-day SMA: | 1.27 | Sell |
| 200-day SMA: | 2.89 | Sell |
| 8-day EMA: | 1.1 | Sell |
| 20-day EMA: | 1.38 | Sell |
| 50-day EMA: | 1.36 | Sell |
| 200-day EMA: | 18.39 | Sell |
CTXR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.37 | Sell |
| 20-day SMA: | 0.38 | Sell |
| 50-day SMA: | 0.47 | Sell |
| 200-day SMA: | 0.66 | Sell |
| 8-day EMA: | 0.37 | Sell |
| 20-day EMA: | 0.39 | Sell |
| 50-day EMA: | 0.47 | Sell |
| 200-day EMA: | 0.65 | Sell |
Seelos Therapeutics Earnings Growth & SEEL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Citius Pharmaceuticals Earnings Growth & CTXR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and an increase next year of $0.33 per share.
Seelos Therapeutics Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Citius Pharmaceuticals Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||